research Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
In this study, 96% of children with CNS tumors receiving MAPK and mTOR inhibitors experienced common, treatable skin reactions, occasionally requiring therapy adjustments.


